CIK: 0001609251 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 18, 2021
Total Value ($000): $288,899 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | 862,848 | $42,556 | 14.7% | $44.29 | +12.6% | COM | 29251M106 |
| UTHR | UNITED THERAPEUTICS CORP | 249,421 | $41,721 | 14.4% | $121.76 | +36.9% | COM | 91307C102 |
| — | TARO PHARMACEUTICAL INDUS | 547,639 | $40,388 | 14.0% | $78.11 | — | COM | M8737E108 |
| REGN | REGENERON PHARMACEUTICALS | 82,698 | $39,128 | 13.5% | $342.96 | +41.2% | COM | 75886F107 |
| BIIB | BIOGEN INC | 138,518 | $38,750 | 13.4% | $311.05 | -13.3% | COM | 09062X103 |
| MCK | MCKESSON CORP | 167,640 | $32,697 | 11.3% | $138.18 | +28.3% | COM | 58155Q103 |
| ALKS | ALKERMES PLC | 1,627,323 | $30,398 | 10.5% | $18.60 | +10.0% | COM | G01767105 |
| — | SURGALIGN HOLDINGS INC | 6,449,408 | $14,060 | 4.9% | $1.82 | — | COM | 86882C105 |
| — | INVACARE CORP | 908,236 | $7,284 | 2.5% | $11.95 | — | COM | 461203101 |
| — | ALEXION PHARMACEUTICALS INC | 6,912 | $1,057 | 0.4% | $97.60 | — | COM | 015351109 |
| ANAB | ANAPTYSBIO INC | 25,690 | $554 | 0.2% | $23.65 | +6.7% | COM | 032724106 |
| — | NEXTCURE INC | 30,603 | $306 | 0.1% | $10.00 | — | COM | 65343E108 |